James Hur (right), a student from Harvard-Westlake School, describes his research on healing radiation wounds at the USC Early Investigator High School (EiHS) & USC CIRM Science, Technology and Research (STAR) Colloquium …
Dr. Andrew McMahon, Dr. Seth Ruffins and the judges of the USC Stem Cell Image of the Month contest would like to congratulate our July 2013 winner, Elisabeth Rutledge, a PhD student …
More than 20 local students are enjoying a summer of hands-on experience in stem research laboratories through the USC Early Investigator High School (EiHS) and the USC CIRM Science, Technology and Research …
USC School of Pharmacy Professor Roberta Diaz Brinton, holder of the R. Pete Vanderveen Chair in Therapeutic Discovery and Development, presented her work on Allopregnanolone and the phase 1 trial that will …
Researchers are learning how to turn regular cells into stem cells, a process called reprogramming. However, some of the mechanisms of the process remain unknown, such as why only a small proportion of the cells can be reprogrammed. Researchers have at least part of the answer: the structure of genes.
Scientists at USC have unlocked the mystery of why new cases of the genetic disease Noonan syndrome are so common—a mutation, which causes the disease, disproportionately increases a normal father’s production of …
With its combination of bone, muscle, joints and more, the human musculoskeletal system is a complicated tangle of connections that can be difficult to repair. That was the challenge facing a panel …
Fibrosis is the process of scar tissue formation. Liver fibrosis can be caused by injury to the liver, chronic viral infection and alcohol abuse. Advanced liver fibrosis can lead to cirrhosis, portal …
What does a bacterial flange actually look like? Going way beyond the microscope, researchers from across several schools at USC and The Scripps Research Institute in La Jolla, Calif., gathered this month …
Over the last decade, osteonecrosis of the jaw (ONJ) has emerged as a devastating and debilitating condition of cancer patients receiving high doses of antiresorptive chemotherapy (bisphosphonates and denosumab). ONJ currently has …